Healthcare Services

Biopharmaceutical Third-Party Logistics Market Growth Expected to Reach $221.14 Billion by 2030 with 8.1% CAGR

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Biopharmaceutical Third-Party Logistics Market Over The Period 2026–2030?

The biopharmaceutical third-party logistics market size has demonstrated substantial growth recently. It is projected to expand from $150.5 billion in 2025 to $161.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. This historical growth can be linked to factors such as increased production of biologics and vaccines, the growing trend of pharmaceutical companies outsourcing their logistics services, the expansion of global biopharmaceutical supply chains, stricter regulatory demands for drug transportation, and the constrained in-house logistics capabilities among biopharma firms.

The biopharmaceutical third-party logistics market is projected to experience substantial expansion in the coming years, reaching $221.15 billion in 2030 with a compound annual growth rate (CAGR) of 8.1%. This anticipated growth is driven by factors such as a rise in demand for personalized medicines, the broadening distribution of cell and gene therapies, increased investments in smart logistics platforms, a heightened emphasis on comprehensive supply chain visibility, and the growing volume of international biopharmaceutical trade. Key trends emerging during this period encompass the greater adoption of sophisticated cold chain logistics solutions, an uptick in the need for temperature-controlled transportation services, the expanding utilization of real-time shipment tracking platforms, the development of specialized biopharma warehousing infrastructure, and a reinforced commitment to regulatory-compliant logistics practices.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12616&type=smp

What Underlying Factors Are Accelerating The Growth Of The Biopharmaceutical Third-Party Logistics Market?

The increasing practice of logistics outsourcing is anticipated to fuel expansion within the biopharmaceutical third-party logistics market. This process entails entrusting an external entity with managing either the entirety or specific segments of a firm’s logistical operations. Specifically, within biopharmaceutical third-party logistics, outsourcing logistics is utilized for delegating cryogenic supply chain management responsibilities to specialized logistics collaborators. As an illustration, data from February 2024, sourced from the Bureau of Transportation Statistics, a US Department of Transportation (DOT) agency, revealed that for-hire freight shipments experienced a 1.8% rise in December 2023 relative to December 2022. Concurrently, the Freight Transportation Services Index climbed from 136.6 in December 2022 to 139.1 in December 2023. Consequently, the expanding trend of outsourcing logistics is projected to significantly boost the development of the biopharmaceutical third-party logistics market.

How Is The Biopharmaceutical Third-Party Logistics Market Divided Into Its Major Segments?

The biopharmaceutical third-party logistics market covered in this report is segmented –

1) By Supply Chain: Cold Chain, Non-Cold Chain

2) By Service: Transportation, Warehousing And Storage, Other Services

3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users

Subsegments:

1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging

2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

Which Market Trends Are Creating New Opportunities In The Biopharmaceutical Third-Party Logistics Market?

Key companies within the biopharmaceutical third-party logistics market are concentrating on innovative strategies, including business expansion in life sciences and healthcare logistics, to strengthen their logistical capacity for pharmaceutical and healthcare products, thereby ensuring effective storage and distribution. This expansion in life sciences and healthcare logistics signifies the deliberate growth of logistics firms to enhance their abilities in transporting and managing medical items, a critical factor for guaranteeing timely delivery and preserving the integrity of temperature-sensitive products vital for patient care. As an illustration, in May 2025, DHL Group, a logistics company from Germany, unveiled the grand opening of its modernized Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. The new facility incorporates ultra cold storage zones, capable of reaching –70°C, along with real-time visibility systems and GDP certified infrastructure, facilitating the secure handling of sensitive biopharmaceuticals such as mRNA vaccines, clinical trial materials, and advanced therapies.

Who Are The Prominent Organizations Shaping The Biopharmaceutical Third-Party Logistics Market?

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Read the full biopharmaceutical third-party logistics market report here:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Which Region Is Projected To Dominate The Biopharmaceutical Third-Party Logistics Market During The Forecast Period?

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical third-party logistics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biopharmaceutical Third-Party Logistics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12616&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical Third-Party Logistics Market 2026, By The Business Research Company

Biopharmaceutical Third Party Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Pharmaceutical Logistics Global Market Report

https://www.thebusinessresearchcompany.com/report/pharmaceutical-logistics-global-market-report

Third Party Logistics 3Pl Market

https://www.thebusinessresearchcompany.com/report/third-party-logistics-3pl-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795